Evidence map›Paper›PMID 42346940›Full record

ArticleMembranes2026

Simulation of GO-PAMAM-Modified Polysulfone Substrate-Based Thin-Film Composite Reverse-Osmosis Membranes for Desalination.

Mohd Muzammil Zubair, Syed Javaid Zaidi

Abstract read
In one paragraph

Article in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohd Muzammil ZubairUNESCO Chair in Desalination and Water Treatment, Center for Advanced Material, Qatar University, Doha P.O. Box 2713, Qatar.
Syed Javaid ZaidiUNESCO Chair in Desalination and Water Treatment, Center for Advanced Material, Qatar University, Doha P.O. Box 2713, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Freshwater scarcity driven by population growth and industrial demand has increased reliance on desalination, where reverse osmosis (RO) is widely applied due to its high separation efficiency. Membrane performance is governed by the balance between water permeability and solute rejection, and attempts to improve this relationship have focused on incorporating nanomaterials to modify membrane structure and transport behavior. In this study, a computational investigation was carried out for thin-film composite (TFC) membranes incorporating graphene oxide-poly(amidoamine) (GO-PAMAM) within the polysulfone substrate to examine its influence on transport under RO conditions. A two-dimensional model was implemented in COMSOL Multiphysics by coupling the Laminar Flow and Transport of Diluted Species interfaces, while permeation across the membrane was described using a solution-diffusion framework parameterized by experimentally determined salt permeability coefficient. Variation in GO-PAMAM loading (0-0.10 wt%) was introduced through intrinsic permeability parameters, enabling direct comparison with experimental data. The simulations reproduced the observed trends, with the membrane containing 0.06 wt% GO-PAMAM showing higher salt rejection, increasing from 78.16% to 90.08% relative to the pristine membrane. The model predicted lower permeate-side solute concentration and a decrease in salt rejection along the membrane length. Model predictions agreed with experiments, with mean relative errors of 1.23% for salt rejection and 7.41% for water flux, demonstrating the ability of the model to capture transport behavior in GO-PAMAM-modified TFC membranes.

Indexed as

computational fluid dynamics (CFD)polysulfone substratereverse osmosis (RO)salt rejectionthin-film composite (TFC)

Identifiers

PMID42346940
PMCPMC13304106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.